From “academic success” to “commercial success” —The model of medical device translation driven by SCI articles

Abstract

For Asia–Pacific countries used to long-term medical device manufacturing, developing innovative medical devices must be rooted in our profound research strength and mature medical productivity. Here, we developed a new model for achieving efficient translation through cooperation among local hospitals, universities, and industries and introduced the project manager system and Key Opinion Leader training. This “From SCI to FDA” model is a pivot for transferring cutting-edge research into valuable medical devices.

Translational potential of this article

This article presents a novel model for translating scientific research into innovative medical devices by fostering collaboration among hospitals, universities, and industries. By integrating clinical insights with academic expertise and industrial capabilities, this model addresses unmet clinical needs and bridges the gap between research and commercialization. Its potential lies in accelerating the translation of cutting-edge research into officially approved products, enhancing medical device innovation, and improving healthcare outcomes globally, particularly in Asia–Pacific countries.